[go: up one dir, main page]

MX2010004481A - Composicion para pella de acido lipoico. - Google Patents

Composicion para pella de acido lipoico.

Info

Publication number
MX2010004481A
MX2010004481A MX2010004481A MX2010004481A MX2010004481A MX 2010004481 A MX2010004481 A MX 2010004481A MX 2010004481 A MX2010004481 A MX 2010004481A MX 2010004481 A MX2010004481 A MX 2010004481A MX 2010004481 A MX2010004481 A MX 2010004481A
Authority
MX
Mexico
Prior art keywords
lipoic acid
pellet composition
acid pellet
composition
pellets
Prior art date
Application number
MX2010004481A
Other languages
English (en)
Inventor
Flavio Villani
Paolo Magri
Antonio Nardi
Annibale Salvi
Original Assignee
Laboratorio Chimico Int Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Chimico Int Spa filed Critical Laboratorio Chimico Int Spa
Publication of MX2010004481A publication Critical patent/MX2010004481A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una composición novedosa basada en pellas de ácido lipóico en un medio lipofílico, si fuera necesario combinado con otros ingredientes activos.
MX2010004481A 2007-10-23 2008-10-23 Composicion para pella de acido lipoico. MX2010004481A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002051A ITMI20072051A1 (it) 2007-10-23 2007-10-23 Composizione a base di pellet di acido lipoico
PCT/IB2008/002835 WO2009053824A1 (en) 2007-10-23 2008-10-23 Lipoic acid pellet composition

Publications (1)

Publication Number Publication Date
MX2010004481A true MX2010004481A (es) 2010-08-02

Family

ID=40313864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004481A MX2010004481A (es) 2007-10-23 2008-10-23 Composicion para pella de acido lipoico.

Country Status (27)

Country Link
US (1) US9820948B2 (es)
EP (1) EP2217220B1 (es)
JP (1) JP5626890B2 (es)
KR (1) KR101599078B1 (es)
CN (1) CN101861144B (es)
AT (1) ATE506053T1 (es)
AU (1) AU2008315667B2 (es)
BR (1) BRPI0816587A2 (es)
CA (1) CA2703152C (es)
CY (1) CY1112122T1 (es)
DE (1) DE602008006454D1 (es)
DK (1) DK2217220T3 (es)
ES (1) ES2363880T3 (es)
HR (1) HRP20110453T1 (es)
IL (1) IL205211A (es)
IT (1) ITMI20072051A1 (es)
MX (1) MX2010004481A (es)
NZ (1) NZ584884A (es)
PL (1) PL2217220T3 (es)
PT (1) PT2217220E (es)
RS (1) RS51712B (es)
RU (1) RU2501558C2 (es)
SI (1) SI2217220T1 (es)
TN (1) TN2010000163A1 (es)
UA (1) UA100394C2 (es)
WO (1) WO2009053824A1 (es)
ZA (1) ZA201002777B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2537081B2 (ja) 1988-10-18 1996-09-25 富士写真フイルム株式会社 磁気記録媒体
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2011099031A1 (en) 2010-02-11 2011-08-18 Zota Health Care Limited Active antioxidants for all age group
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
US11337960B2 (en) 2014-10-24 2022-05-24 Pre-D Partners Llc Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
EP3593795B1 (en) * 2016-12-14 2025-11-12 Cidat, S.A. De C.V. Combinations and methods for the treatment of neuropathic pain
CN106729725A (zh) * 2017-03-21 2017-05-31 北京百慧生化制药有限责任公司 硫辛酸作为抗氧化剂在多烯酸乙酯制剂或蛹油α‑亚麻酸乙酯制剂中的应用
IT202200007232A1 (it) * 2022-04-12 2023-10-12 Uriach Italy S R L Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
WO2023199241A1 (en) * 2022-04-12 2023-10-19 URIACH ITALY S.r.l. Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0774166B2 (ja) * 1987-02-06 1995-08-09 信越化学工業株式会社 徐放性被覆薬剤の製造方法
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6479069B1 (en) * 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US20020098247A1 (en) * 2000-11-02 2002-07-25 Komorowski James R. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
ITMI20012732A1 (it) * 2001-12-20 2003-06-20 Health Pharma S R L Integratore alimentare per neuropatici
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
CN1694695A (zh) * 2002-11-07 2005-11-09 帝斯曼知识产权资产管理有限公司 包含表没食子儿茶素没食子酸酯的新颖的营养药物性组合物
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20060182729A1 (en) 2005-02-17 2006-08-17 Prasad Kedar N Combat/training antioxidant micronutrient formulation and method of administration
JP2006298831A (ja) * 2005-04-21 2006-11-02 Sumitomo Shoji Chemicals Co Ltd αリポ酸粉体被覆物及びその製造方法、並びにαリポ酸含有食品
JP5157001B2 (ja) * 2005-04-30 2013-03-06 ビーエイチエヌ株式会社 安定化α−リポ酸組成物及びその利用
US20060270625A1 (en) * 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy
WO2007032340A1 (ja) * 2005-09-12 2007-03-22 Kyowa Hakko Kogyo Co., Ltd. α－リポ酸含有組成物
WO2007123284A1 (en) * 2006-04-26 2007-11-01 Dpi Solutions, Inc. Alpha lipoic acid capsule composition stabilized in water phase and method for preparing the same
ITMI20061024A1 (it) * 2006-05-25 2007-11-26 Eurand Pharmaceuticals Ltd Pellet a base di acido lipoico

Also Published As

Publication number Publication date
CA2703152C (en) 2016-02-23
PL2217220T3 (pl) 2011-09-30
JP5626890B2 (ja) 2014-11-19
SI2217220T1 (sl) 2011-06-30
IL205211A (en) 2013-01-31
EP2217220A1 (en) 2010-08-18
HRP20110453T1 (hr) 2011-07-31
CN101861144A (zh) 2010-10-13
CN101861144B (zh) 2013-03-13
AU2008315667A1 (en) 2009-04-30
NZ584884A (en) 2011-11-25
DK2217220T3 (da) 2011-08-01
PT2217220E (pt) 2011-07-13
CY1112122T1 (el) 2015-11-04
JP2011500784A (ja) 2011-01-06
ZA201002777B (en) 2011-06-29
ES2363880T3 (es) 2011-08-18
US9820948B2 (en) 2017-11-21
EP2217220B1 (en) 2011-04-20
ATE506053T1 (de) 2011-05-15
DE602008006454D1 (de) 2011-06-01
IL205211A0 (en) 2010-12-30
TN2010000163A1 (en) 2011-11-11
BRPI0816587A2 (pt) 2015-03-03
UA100394C2 (en) 2012-12-25
RU2501558C2 (ru) 2013-12-20
AU2008315667B2 (en) 2013-02-28
ITMI20072051A1 (it) 2009-04-24
RU2010120706A (ru) 2011-11-27
RS51712B (sr) 2011-10-31
CA2703152A1 (en) 2009-04-30
WO2009053824A1 (en) 2009-04-30
US20110129442A1 (en) 2011-06-02
KR20100089848A (ko) 2010-08-12
KR101599078B1 (ko) 2016-03-02

Similar Documents

Publication Publication Date Title
IL205211A0 (en) Lipoic acid pellet composition
EP2338622A3 (en) Stabilized lithium metal powder for li-ion application, composition and process.
MX2010009850A (es) Analogos de insulina acilados y etabilizados contra proteasas.
MX2008008437A (es) Formateo condicional multiple.
WO2010043884A3 (en) Lithium containing transition metal sulfide compounds
WO2009149956A3 (en) Fusion protein and use thereof
ZA201008715B (en) Oxygen-scavenging mixtures
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
WO2011029866A3 (en) Polymerase compositions and uses
MY149433A (en) Nutritional compositions containing punicalagins
WO2009075329A1 (ja) 分解性を調整したゼラチン組成物
MY152388A (en) Composition and method for controlling plant diseases
MX2008009830A (es) Efecto del inhibidor bst2.
MX2009012569A (es) Peptidos rumc con actividad antimicrobiana.
WO2007112039A3 (en) Methods and compositions for modulating t cell and/or b cell activation
WO2009010298A3 (en) Paullone derivatives and its use
WO2011017346A3 (en) Fast-acting naproxen composition with reduced gastrointestinal effects
Kawabata Studies on the behaviour and ecology of hatchery-reared black-spot tuskfish for its optimal release strategies
장수형 42page 70page
고산 30page 92page
SI2651392T1 (sl) Trdni sestavki, ki vsebujejo flurbiprofen, postopki za njihovo pripravo in njihova uporaba
WO2008090850A1 (ja) 抗癌剤の効果増強剤
박찬홍 48page 70page
이문호 et al. 48page 78page
MX2009008991A (es) Solucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores.

Legal Events

Date Code Title Description
FG Grant or registration